InMode Ltd. Stock: price and insider trades · United States
InMode Ltd.: what insiders have been doing
InMode Ltd. is a listed company. Filings by its managers are published through SEC (Form 4). In the past year (8 November 2025 to 8 November 2026), 4 filings came from 4 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Over the last twelve months, not one insider purchase of InMode Ltd. stock was filed.
Across the 5,813 companies tracked on its exchange, the median is 19 filings; at 4 filings, this issuer sits below that mark. The 20-F for the year ended 31 December 2025 shows 370.5 m USD of revenue and 93.8 m USD of net income.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Analyst consensus: bullish or bearish?
Analysts rate InMode Ltd. Hold (neutral), based on 3 analysts. Average price target: US$16.17.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 14,000 shares0Ordinary SharesSEC:0001178913-26-003857:0
- 2,000 shares0Ordinary SharesSEC:0001178913-26-003731:0
- 2,000 sharesOrdinary SharesSEC:0001178913-26-003733:0
- 2,000 shares0Ordinary SharesSEC:0001178913-26-003735:0
4 of 4 declarations
About InMode Ltd.
InMode Ltd. is a medical technology company that provides innovative solutions for aesthetic surgery and medicine. It is listed on NASDAQ under the ticker INMD.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
